|

GPC3 CD146 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Essen Biotech1

Indications

  • Ovarian Sarcoma1
  • Ovarian Cancer Stage IV1
  • Ovarian Carcinoma1
  • Ovarian Cancer1
  • Cancer1

Other1 trial

Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.